QuickView for ADORA1;jsessionid=2111B80A389BE5054565A651D218425B;jsessionid=703A5CD0FCC2B8326AEE59A4B033C6E3;jsessionid=E9477E9FF3B8C4C4B11E9D58F67FA4F9;jsessionid=B98A841A56233A134C5190B578DAE226;jsessionid=69775B10D2C8D21A622C251813CB4A5F;jsessionid=6E3B57085BAC341C46782D00D8A8680E;jsessionid=8AB88685DA501FDA8B662808D4A26D89;jsessionid=519B41DEAA02E71678D4FB69C0953245 (gene)

1. Ex Vivo Feedback Control of Neurotransmission Using a Photocaged Adenosine A1 Receptor Agonist.
2. Lack of efficacy of a partial adenosine A1 receptor agonist in neuropathic pain models in mice.
3. Dopamine Release in Nucleus Accumbens Is under Tonic Inhibition by Adenosine A1 Receptors Regulated …
4. The role of adenosine A1 receptor agonist in adenosine augmentation therapy for patients with refrac…
5. Analgesic action of adenosine A1 receptor involves the dephosphorylation of glycine receptor α1ins s…

There were no clinical trials for ADORA1;jsessionid=2111B80A389BE5054565A651D218425B;jsessionid=703A5CD0FCC2B8326AEE59A4B033C6E3;jsessionid=E9477E9FF3B8C4C4B11E9D58F67FA4F9;jsessionid=B98A841A56233A134C5190B578DAE226;jsessionid=69775B10D2C8D21A622C251813CB4A5F;jsessionid=6E3B57085BAC341C46782D00D8A8680E;jsessionid=8AB88685DA501FDA8B662808D4A26D89;jsessionid=519B41DEAA02E71678D4FB69C0953245